These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29269313)

  • 1. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
    Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
    Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.
    Khalili H; Huang ES; Jacobson BC; Camargo CA; Feskanich D; Chan AT
    BMJ; 2012 Jan; 344():e372. PubMed ID: 22294756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.
    Lochhead P; Hagan K; Joshi AD; Khalili H; Nguyen LH; Grodstein F; Chan AT
    Gastroenterology; 2017 Oct; 153(4):971-979.e4. PubMed ID: 28728964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
    Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women.
    Rist PM; Jiménez MC; Tworoger SS; Hu FB; Manson JE; Sun Q; Rexrode KM
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):68-75. PubMed ID: 28888344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis.
    Malhotra K; Katsanos AH; Bilal M; Ishfaq MF; Goyal N; Tsivgoulis G
    Stroke; 2018 Feb; 49(2):312-318. PubMed ID: 29339434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
    Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
    PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.
    Saber H; Yakoob MY; Shi P; Longstreth WT; Lemaitre RN; Siscovick D; Rexrode KM; Willett WC; Mozaffarian D
    Stroke; 2017 Oct; 48(10):2678-2685. PubMed ID: 28830976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women.
    Sato S; Iso H; Noda H; Kitamura A; Imano H; Kiyama M; Ohira T; Okada T; Yao M; Tanigawa T; Yamagishi K; Nakamura M; Naito Y; Shimamoto T
    Stroke; 2006 Oct; 37(10):2488-92. PubMed ID: 16946147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
    Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
    Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
    Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors is associated with lower rates of first-time ischemic stroke in community-dwelling elderly.
    Schmilovitz-Weiss H; Gingold-Belfer R; Peleg N; Grossman A; Issa N; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Shirin H; Weiss A
    Br J Clin Pharmacol; 2021 Mar; 87(3):1187-1193. PubMed ID: 32692459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.